{"database": "lobbying", "table": "lobbying_activities", "rows": [[2470933, "e6951ffd-d508-4153-b022-8afb63f21c31", "Q2", "VAN SCOYOC ASSOCIATES", 39837, "ZEBRA TECHNOLOGIES CORP.", 2020, "second_quarter", "CSP", "Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation\n\nTemperature monitoring technology for COVID-19 vaccines", "HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2020-07-17T10:45:41.817000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2470933"], "units": {}, "query_ms": 107.00668999925256, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}